Home/Filings/4/0000899243-19-008140
4//SEC Filing

FLESHER GREGORY J. 4

Accession 0000899243-19-008140

CIK 0001404281other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:23 PM ET

Size

7.5 KB

Accession

0000899243-19-008140

Insider Transaction Report

Form 4
Period: 2019-03-14
FLESHER GREGORY J.
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2019-03-14+25,000171,556 total
  • Award

    Stock Option (Right to Buy)

    2019-03-14+90,00090,000 total
    Exercise: $3.72Exp: 2029-03-14Common Stock (90,000 underlying)
Footnotes (2)
  • [F1]This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date.
  • [F2]This option represents a right to purchase a total of 90,000 shares of the Issuer's Common Stock, which will vest in equal quarterly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Issuer

Novus Therapeutics, Inc.

CIK 0001404281

Entity typeother

Related Parties

1
  • filerCIK 0001705287

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:23 PM ET
Size
7.5 KB